TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Buerger’s disease

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger’s Disease Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger’s Disease Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia Contrast Enhanced Ultrasound and Muscle Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger’s Disease Treatment of Thromboangiitis Obliterans (Buerguer’s Disease) With Bosentan A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease